
By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
latest_posts
- 1
Solid Living Tips: Experiences from a Wellness Fan - 2
Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide - 3
The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit - 4
Israel explores creation of int'l force with Greece, Cyprus to deter Turkey - 5
An Aide On Upgrading Your FICO rating
Compassion and Association: Building Significant Connections
Kristin Cavallari was the teen queen bee of 'Laguna Beach.' Now she's a 'cringey' mom.
Politics at the table? Drinking the wine you brought? An etiquette expert's Thanksgiving dos and don'ts.
From Dread to Certainty: Individual Accounts of Strengthening
Why most Jewish Israelis back the death penalty for terrorists
NASA Perseverance rover sees megaripples on Mars | Space photo of the day for Jan. 7, 2026.
Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
Jesse Jackson hospitalized, under observation for a neurodegenerative condition
A Couple of Reasonable Guitars for 2024













